TTK Healthcare Limited has submitted its mandatory regulatory compliance certificate for the quarter ended March 31, 2026, in accordance with SEBI (Depositories and Participants) Regulations, 2018. The submission demonstrates the company's commitment to maintaining regulatory compliance and transparency in securities handling processes.

Regulatory Compliance Details

The certificate was submitted under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, dated April 02, 2026. This quarterly compliance requirement ensures proper handling of securities dematerialization processes and maintains investor protection standards.

Registrar and Transfer Agent Certification

Data Software Research Co. Pvt. Ltd., Chennai, serving as TTK Healthcare's Registrar and Share Transfer Agent, issued the compliance certificate. The certification confirms adherence to dematerialization requirements and proper securities handling procedures.

The certificate specifically confirms two critical compliance aspects:

• Securities comprised in the certificates have been listed on stock exchanges
• Certificates have been duly verified, mutilated, cancelled, and depository names substituted in records as registered owners

Regulatory Submissions

TTK Healthcare submitted the compliance documentation to multiple regulatory bodies and market infrastructure institutions to ensure comprehensive regulatory adherence.

The submission was signed by Gowry A Jaishankar, DGM – Legal & Company Secretary, with digital signature authentication dated April 02, 2026. This quarterly compliance certificate submission reflects TTK Healthcare's ongoing commitment to regulatory transparency and proper securities management practices, ensuring investor confidence and regulatory adherence.

TTK Healthcare Limited has announced the opening of a special window for the transfer and dematerialization of physical securities, following a SEBI circular dated January 30, 2026. The healthcare company has taken proactive steps to inform shareholders about this regulatory opportunity through multiple communication channels.

SEBI Special Window Details

The special window has been established pursuant to SEBI Circular on Ease of Doing Investment – Special Window for Transfer and Dematerialisation of Physical Securities. This initiative provides shareholders with a structured mechanism to convert their physical securities holdings into electronic format.

Compliance and Communication

TTK Healthcare has fulfilled its regulatory disclosure obligations under Regulation 30 by informing both BSE Limited and National Stock Exchange of India Limited about the special window opening. The company published the notice in Business Standard (English Version) across four editions on Tuesday, February 17, 2026.

Multi-Channel Approach

The company has adopted a comprehensive communication strategy to reach shareholders:

• Print Media: Published in Business Standard newspaper
• Digital Platform: Posted on company's LinkedIn page
• Corporate Website: Made available under Investor Relations section at www.ttkhealthcare.com
• Stock Exchanges: Formal disclosure to BSE and NSE

Shareholder Benefits and Restrictions

The special window covers transfer requests that were previously submitted but rejected or remained unattended due to document deficiencies or process issues. However, certain cases are excluded from this window, including disputes between transferor and transferee, and securities already transferred to the Investor Education and Protection Fund (IEPF).

Contact Information for Assistance

Shareholders seeking assistance with the transfer process can contact the company's Registrar and Transfer Agent, M/s Data Software Research Co. Pvt. Ltd. For queries, shareholders may write to investorcare@ttkhealthcare.com or dsrc@dsrc-cid.in . The notice was signed by Gowry A Jaishankar, DGM - Legal & Company Secretary, and digitally authenticated on February 18, 2026.